<DOC>
	<DOCNO>NCT01537575</DOCNO>
	<brief_summary>Postpolio syndrome condition affect many polio survivor year acute infection cause symptom increase new symptom develop . Proinflammatory cytokine production within central nervous system ( CNS ) indicate underlying inflammatory process , amenable immunomodulatory therapy . In study investigator seek confirm antiinflammatory treatment intravenous immunoglobulin improve disease .</brief_summary>
	<brief_title>Intravenous Immunoglobulins Post-Polio Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Postpoliomyelitis Syndrome</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>history acute poliomyelitis increase muscle weakness , muscle fatigue pain muscle group previously affect poliomyelitis diagnosis postpolio syndrome accord criterion Halstead Rossi clinically relevant systemic disease malignancy hypothyroidism diabetes mellitus fully control medical therapy medical orthopedic disorder could give rise symptom mimic postpolio syndrome condition associate prolonged coagulation time serum IgA deficiency previous allergic reaction IVIG bodymass index great 30 immunemodulating treatment IVIG within precede 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>